Jane Perlmutter

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract PS4-09-08: Expanding Diversity through Innovation: Development of the I-SPY ACCESS Initiative for the I-SPY2.2 and DCIS RECAST Clinical Trials

  Clinical Cancer Research · 2026-02-17

• Abstract RF5-06: Pathologic complete response rates (pCR) after the novel HER2 ADC ARX788: Results from the I-SPY2.2 trial

  Clinical Cancer Research · 2026-02-17

• Abstract PS1-01-09: Real-time monitoring for drug-induced interstitial lung disease with Trastuzumab Deruxtecan and Rilvegostomig combination therapy prevents persistent, symptomatic disease: Safety insights from the I-SPY2.2 platform trial

  Clinical Cancer Research · 2026-02-17

• Abstract RF1-04: Early Adverse Symptoms Predict Response to Treatment Among Patients in the I-SPY Trial

  Clinical Cancer Research · 2026-02-17

• Abstract PD6-09: Quantifying the Contribution of Doxorubicin and Cyclophosphamide (AC) to Pathologic Response Following Neoadjuvant Taxane Therapy: Analysis of the I-SPY2 TRIAL

  Clinical Cancer Research · 2026-02-17

• Abstract PS3-11-10: Neoadjuvant HSP90 inhibition with ganetespib significantly improves distant relapse-free survival in I-SPY2 patients with HER2-negative breast cancer with low expression of immune genes and no DNA repair deficiency

  Clinical Cancer Research · 2026-02-17

• Abstract PD11-03: Predicting treatment outcomes in breast cancer from H&E slides using pathology foundation models with multiple instance learning

  Clinical Cancer Research · 2026-02-17

• Abstract PS1-01-05: Pneumonitis but not other immune related adverse events (irAEs) associate with pre-treatment immune signatures in early-stage breast cancer patients receiving neoadjuvant immunotherapy (IO): results from 5 IO arms in I-SPY2

  Clinical Cancer Research · 2026-02-17

• Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trialPreprint

  Research Square · 2026-02-11

• Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

  UNC Libraries · 2026-01-09

• Abstract C051: Emerging Novel Targets to treat non-responding HER2-negative breast cancer patients: The neoadjuvant I-SPY2 TRIAL 2300 patient Omics data and organoid studies

  Molecular Cancer Therapeutics · 2025-10-22

• Reducing Protocol Variability Enhances Predictive Performance of Breast MRI Biomarkers in a Multicenter Clinical Trial

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• Functional Tumor Volume by Subtype Improves Prediction of Pathological Complete Response in Breast Cancer

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-29

• ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-23

• Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-23 · 2 citations

• ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

  Annals of Surgical Oncology · 2025-08-21

• Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial

  Annals of Surgical Oncology · 2025-07-24 · 5 citations

• Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

  Annals of Surgical Oncology · 2025-07-23 · 1 citations

• Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial

  Breast Cancer Research · 2025-06-23 · 8 citations